|
Volumn 26, Issue 7, 2004, Pages 425-429
|
Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CHOP B PROTOCOL;
CHOP-B PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CHILD;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
NASOPHARYNX TUMOR;
NONHODGKIN LYMPHOMA;
PROGNOSIS;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CHILD;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
NASOPHARYNGEAL NEOPLASMS;
NEOPLASM STAGING;
PREDNISONE;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
VINCRISTINE;
|
EID: 16644385966
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|